导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 33.17% | 29/330 |
| 近一周 | -0.20% | 138/359 |
| 近一月 | 7.35% | 2/358 |
| 近一季 | 28.70% | 2/354 |
| 近半年 | 42.29% | 6/345 |
| 近一年 | 27.56% | 63/329 |
| 近两年 | 47.33% | 92/274 |
| 近三年 | 44.12% | 73/193 |
| 成立以来 | 69.06% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-9.72% 308/341 |
1.92% 218/349 |
19.29% 97/355 |
- - |
| 2024 | -0.16% 230/330 |
5.69% 127/280 |
-2.36% 217/310 |
5.99% 146/319 |
-8.72% 269/330 |
| 2023 | 6.71% 96/276 |
-7.87% 185/205 |
8.60% 67/230 |
-10.87% 224/262 |
19.65% 1/276 |
| 2022 | -25.51% 121/202 |
-18.61% 119/153 |
-17.26% 128/164 |
6.14% 13/189 |
4.22% 138/202 |
| 2021 | -19.49% 83/151 |
-2.98% 277/312 |
-0.25% 246/328 |
-7.03% 200/358 |
-10.52% 130/151 |
| 2020 | 41.74% 10/104 |
-18.24% 209/280 |
40.65% 8/295 |
-0.86% 200/299 |
24.32% 14/305 |
| 2019 | 28.17% 25/89 |
23.88% 6/258 |
-3.15% 231/267 |
-13.24% 243/253 |
23.12% 1/266 |
| 2018 | -15.72% 60/80 |
- - |
- - |
0.43% 138/225 |
-23.99% 210/241 |
| 2017 | 30.76% 7/69 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 嘉实标普生物科技精选行业ETF(QDII) | 1.2840 | 29.58% |
| 易方达标普生物科技美元汇A | 0.2453 | 28.70% |
| 易方达标普生物科技美元汇C | 0.2420 | 28.65% |
| 易方达标普生物科技人民币C | 1.7091 | 27.95% |
| 汇添富纳斯达克生物科技ETF(QDII) | 1.4675 | 18.71% |
| 广发生物科技指数美元(QDII)C | 0.2058 | 16.69% |
| 华泰柏瑞中韩半导体ETF(QDII) | 2.3391 | 16.34% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现钞 | 1.3491 | 16.14% |
| 广发生物科技指数人民币(QDII)A | 1.4780 | 16.14% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3491 | 16.14% |
| 易方达标普生物科技美元汇A VS. 天弘恒生科技指数(QDII)C(012349) |